CBNY repors net loss of $3.92 million for nine months ended

April 23, 2019 

Ciboney Group Limited (CBNY) for the nine months ended February 28, 2019, financial Income declined by 97% to total $43,000 from $1.68 million in February 2018.

No exchange loss was booked for the period relative to a loss of $103,000 for the corresponding period in 2018.

Group Operating Expenses totalled $3.96 million for the period relative to $5.78 million for the corresponding period in 2018 a 31% decline.

The company reported net loss after taxation of $3.92 million, this compares with the profit of $252.48 million in 2018.

Net loss per share was $0.72 cents for the period (2018: earnings per share of $46.24 cents). The trailing twelve months earnings per a share is $5.88 cents. The number of shares used in the calculations is 546,000,000.  CBNY stock price closed the trading period at a price of $0.12 on April 18, 2019

Balance Sheet at a glance:

Total Assets as at February 28, 2019 amounted to $14.63 million, down from $205.90 million as at February 28, 2018. The main reason for the decline in total asset ‘Cash and Cash Equivalents’ contracting 96% to total $8.82 million compared to the $200.10 million reported in 2018.

Shareholders’ Equity amounted to $10.20 million, a decline relative to the $204.82 million reported in 2018. As such, the book per share stood at $0.019 cents as at as at February 28, 2019 (2018: $0.375 cents).

Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

 

 

 

 

 

 

More Stories from the Market
shutterstock_537598660
March12, 2026 Blue Power Group Limited (BPOW) Unaudited financials for the nine months ended January 31, 2026: Blue Power Group Limited (BPOW) for …
shutterstock_148562033
March 12, 2026   Wisynco Group Limited (WISYNCO) has advised that on March 9, 2026, Executives sold a total of 2,594,821 WISYNCO shares. …
shutterstock_453968572
March 12, 2026 United States: US Trade Gap Narrowed in January by More Than Projected   The US trade deficit narrowed in January as export…
shutterstock_342262439
March 11, 2025   Indies Pharma Jamaica Limited (INDIES) has advised that at a meeting of its Board of Directors to be held on March 23, 202…
shutterstock_453968572
March 11, 2025   Kintyre Holdings (JA) Limited (KNTYR) has advised that the Company has been notified that a group of principal shareholder…
shutterstock_148562033
March 11, 2026   A.S. Bryden & Sons Holdings Limited (ASBH) has advised that on February 16, 2026, a connected party purchased 282,704 …
shutterstock_148562033
March 11, 2025   Seprod Limited (SEP) has advised that on February 20, 2026, a Director sold 5,787,413 SEP shares and a connected party pur…
shutterstock_537598660
March 11, 2026 Weekly Pick 11.03.2026 JMMBGL Disclaimer: Analyst Certification -The views expressed in this research report accurately refl…